Literature DB >> 14498342

A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients.

B C SCHIELE, N D VESTRE, K E STEIN.   

Abstract

Entities:  

Keywords:  PLACEBOS; TRANQUILIZING AGENTS/therapy

Mesh：

Substances：

Year:  1961        PMID： 14498342

Source DB:  PubMed          Journal:  J Clin Exp Psychopathol Q Rev Psychiatry Neurol        ISSN： 0447-9122


× No keyword cloud information.
  6 in total

1.  A DOUBLE-BLIND COMPARISON OF THIORIDAZINE AND CHLORPROMAZINE.

Authors:  J R STABENAU; D R GRINOLS
Journal:  Psychiatr Q       Date:  1964-01

Review 2.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

3.  Prophylactic effect of neuroleptics in symptom-free schizophrenics.

Authors:  T Nishikawa; A Tsuda; M Tanaka; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 4.  Trifluoperazine for schizophrenia.

Authors:  L O Marques; M S Lima; B G O Soares
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 5.  Thioridazine for schizophrenia.

Authors:  M Fenton; J Rathbone; J Reilly; A Sultana
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 6.  Trifluoperazine versus placebo for schizophrenia.

Authors:  Kai Koch; Kamel Mansi; Euan Haynes; Clive E Adams; Stephanie Sampson; Vivek A Furtado
Journal:  Cochrane Database Syst Rev       Date:  2014-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.